Phase I CD22 CAR T-cell trial updates

被引：3

作者：

Shah, Nirali N. ^{[1
]}

Shalabi, Haneen ^{[1
]}

Yates, Bonnie ^{[1
]}

Yuan, Constance ^{[1
]}

Qin, Haiying ^{[1
]}

Ombrello, Amanda ^{[2
]}

Wang, Hao-Wei ^{[1
]}

Hoffman, Leah ^{[1
]}

Minh Tran ^{[3
]}

Panch, Sandhya ^{[3
]}

Stetler-Stevenson, Maryalice ^{[1
]}

Jin, Jianjian ^{[1
]}

Mackall, Crystal ^{[4
]}

Highfill, Steve ^{[3
]}

Stroncek, David ^{[3
]}

Fry, Terry J. ^{[5
]}

机构：

[1] NCI, Bethesda, MD 20892 USA

[2] NHGRI, Bethesda, MD 20892 USA

[3] NIH, Bldg 10, Bethesda, MD 20892 USA

[4] Stanford, Palo Alto, CA USA

[5] Univ Colorado, Childrens Hosp Colorado, Denver, CO 80202 USA

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.SABCS18-LB-146

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-146

引用

页数：4

共 50 条

[11] Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)
Schultz, Liora M.
Muffly, Lori S.
Spiegel, Jay Y.
Ramakrishna, Sneha
Hossain, Nasheed
Baggott, Christina
Sahaf, Bita
Patel, Shabnum
Craig, Juliana
Yoon, Jenny
Kadapakkam, Meena
Majzner, Robbie G.
Frank, Matthew J.
Erickson, Courtney
Marcy, Anne Cunniffe
Fujimoto, Michelle
Bhatia, Neehar
Meyer, Everett H.
Kong, Katherine A.
Egeler, Emily
Mavroukakis, Sharon
Qin, Haiying
Fry, Terry J.
Feldman, Steven A.
Miklos, David B.
Mackall, Crystal L.
Davis, Kara L.
BLOOD, 2019, 134
[12] CD22 CAR Optimization for Improved in-Human Activity Following Inadequate CD22 CAR Activity in Phase 1 Clinical Trial PLAT-04
Summers, Corinne
Baxter, Blake
Annesley, Colleen
Yokoyama, Jason
Rhea, Stephanie
Huang, Wenjun
Wilson, Ashley
Park, Julie R.
Orentas, Rimas J.
Jensen, Michael C.
Gardner, Rebecca A.
BLOOD, 2021, 138
[13] Be cautious to adopt a second CAR T-cell infusion after failure of CD19/CD22 cocktail CAR T-cell therapy in relapsed/refractory B-NHL
Wang, Gaoxiang
Huang, Meijuan
Jiang, Lijun
Zhang, Xiaoying
Wang, Zhenhao
Yu, Qiuxia
Li, Dengju
Yang, Yang
Yang, Xin
Cao, Yang
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (05)
[14] Be Cautious to Adopt a Second CAR T-Cell Infusion after Failure of CD19/CD22 Cocktail CAR T-Cell Therapy in Relapsed/Refractory B-NHL
Yang, Xin
Wang, Gaoxiang
Zhang, Xiaoying
Yu, Qiuxia
Cao, Yang
Huang, Liang
BLOOD, 2022, 140 : 4604 - 4605
[15] CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Spiegel, Jay Y.
Patel, Shabnum
Muffly, Lori
Hossain, Nasheed M.
Oak, Jean
Baird, John H.
Frank, Matthew J.
Shiraz, Parveen
Sahaf, Bita
Craig, Juliana
Iglesias, Maria
Younes, Sheren
Natkunam, Yasodha
Ozawa, Michael G.
Yang, Eric
Tamaresis, John
Chinnasamy, Harshini
Ehlinger, Zach
Reynolds, Warren
Lynn, Rachel
Rotiroti, Maria Caterina
Gkitsas, Nikolaos
Arai, Sally
Johnston, Laura
Lowsky, Robert
Majzner, Robbie G.
Meyer, Everett
Negrin, Robert S.
Rezvani, Andrew R.
Sidana, Surbhi
Shizuru, Judith
Weng, Wen-Kai
Mullins, Chelsea
Jacob, Allison
Kirsch, Ilan
Bazzano, Magali
Zhou, Jing
Mackay, Sean
Bornheimer, Scott J.
Schultz, Liora
Ramakrishna, Sneha
Davis, Kara L.
Kong, Katherine A.
Shah, Nirali N.
Qin, Haiying
Fry, Terry
Feldman, Steven
Mackall, Crystal L.
Miklos, David B.
NATURE MEDICINE, 2021, 27 (08) : 1419 - +
[16] Transcriptional Profiling Associated with CD22 CAR T Cell Clinical Response in LBCL
Kramer, Anne Marijn
Hamilton, Mark P.
Prabhu, Snehit
Desai, Moksha
Kuo, Adam
Ehlinger, Zachary
Agarwal, Neha
Su, Yi-Jiun
Gkitsas, Nikolaos
Fowler, Carley
Keerthi, Vimal
Retherford, Aidan
Klysz, Dorota
Tunuguntla, Ramya
Feldman, Steven
Sahaf, Bita
Baird, John H.
Muffly, Lori S.
Mackall, Crystal L.
Miklos, David B.
Good, Zinaida
Frank, Matthew J.
BLOOD, 2023, 142
[17] CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Jay Y. Spiegel
Shabnum Patel
Lori Muffly
Nasheed M. Hossain
Jean Oak
John H. Baird
Matthew J. Frank
Parveen Shiraz
Bita Sahaf
Juliana Craig
Maria Iglesias
Sheren Younes
Yasodha Natkunam
Michael G. Ozawa
Eric Yang
John Tamaresis
Harshini Chinnasamy
Zach Ehlinger
Warren Reynolds
Rachel Lynn
Maria Caterina Rotiroti
Nikolaos Gkitsas
Sally Arai
Laura Johnston
Robert Lowsky
Robbie G. Majzner
Everett Meyer
Robert S. Negrin
Andrew R. Rezvani
Surbhi Sidana
Judith Shizuru
Wen-Kai Weng
Chelsea Mullins
Allison Jacob
Ilan Kirsch
Magali Bazzano
Jing Zhou
Sean Mackay
Scott J. Bornheimer
Liora Schultz
Sneha Ramakrishna
Kara L. Davis
Katherine A. Kong
Nirali N. Shah
Haiying Qin
Terry Fry
Steven Feldman
Crystal L. Mackall
David B. Miklos
Nature Medicine, 2021, 27 : 1419 - 1431
[18] CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL
Ghorashian, Sara
Lucchini, Giovanna
Richardson, Rachel
Nguyen, Kyvi
Terris, Craig
Guvenel, Aleks
Oporto-Espuelas, Macarena
Yeung, Jenny
Pinner, Danielle
Chu, Jan
Williams, Lindsey
Ko, Ka-Yuk
Walding, Chloe
Watts, Kelly
Inglott, Sarah
Thomas, Rebecca
Connor, Christopher
Adams, Stuart
Gravett, Emma
Gilmour, Kimberly
Lal, Alka
Kunaseelan, Sangeetha
Popova, Bilyana
Lopes, Andre
Ngai, Yenting
Hackshaw, Allan
Kokalaki, Evangelia
Carulla, Milena Balasch
Mullan, Khushnuma
Lazareva, Arina
Pavasovic, Vesna
Rao, Anupama
Bartram, Jack
Vora, Ajay
Chiesa, Robert
Silva, Juliana
Rao, Kanchan
Bonney, Denise
Wynn, Robert
Pule, Martin
Hough, Rachael
Amrolia, Persis J.
BLOOD, 2024, 143 (02) : 118 - 123
[19] Upregulation of CD22 by Chidamide promotes CAR T cells functionality
Yang, Xin
Yu, Qiuxia
Xu, Hao
Zhou, Jianfeng
SCIENTIFIC REPORTS, 2021, 11 (01)
[20] Immobilizing A Moving Target: CAR T Cells Hit CD22
Guedan, Sonia
Delgado, Julio
CLINICAL CANCER RESEARCH, 2019, 25 (17) : 5188 - 5190

← 1 2 3 4 5 →